Mesenchyme Stem Cells low-dose group
Sponsors
Maternal and Child Health Hospital of Foshan
Conditions
Cicatrix
Phase 2
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
CompletedNCT02772289
Start: 2016-11-30End: 2019-03-31Updated: 2019-05-07
The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
WithdrawnNCT04034615
Start: 2021-05-20End: 2022-06-01Updated: 2022-12-21